Showing results (11-20 of 156) with videos related to
Sort By:
Pageof 16
Endocrinology|December 1, 1979
Effects of estradiol and the antiestrogen tamoxifen on steroid hormone receptor concentration and nuclear ribonucleic acid polymerase activities in rat uteriP Davies, J S Syne, R I NicholsonEuropean Journal of Cancer & Clinical Oncology|January 1, 1984
The measurement of tamoxifen and metabolites in the rat and relationship to the response of DMBA-induced mammary tumoursC P Daniel, S J Gaskell, R I NicholsonBritish Journal of Cancer|December 1, 1986
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630P N Plowman, R I Nicholson, K J WalkerClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2002
Prospects for combining hormonal and nonhormonal growth factor inhibitionA E Wakeling, R I Nicholson, J M GeeEuropean Journal of Cancer (Oxford, England : 1990)|October 13, 2001
EGFR and cancer prognosisR I Nicholson, J M Gee, M E HarperBritish Journal of Cancer|October 1, 1984
Quantitative aspects of the E2 receptor assay for human breast tumour cytosol using dextran-coated charcoalD W Wilson, G Richards, R I Nicholson, et al.Endocrine-Related Cancer|August 23, 2005
Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancerR Duncan, M J Vicent, F Greco, et al.Trends in Molecular Medicine|February 28, 2009
Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activationC Hogstrand, P Kille, R I Nicholson, et al.European Journal of Cancer & Clinical Oncology|November 1, 1982
Studies with steroid-fluorescein conjugates on oestrogen target tissuesB G Joyce, R I Nicholson, M S Morton, et al.The Journal of Endocrinology|December 1, 1979
Determination of tamoxifen and an hydroxylated metabolite in plasma from patients with advanced breast cancer using gas chromatography-mass spectrometryC P Daniel, S J Gaskell, H Bishop, et al.Pageof 16